Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRC
– Preliminary Data from Phase 1 Study of CORAL Expected Mid-year – – Study will Assess Antibody and CD8+ T...
Month: March 2021
Syneos Health Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
Science 37’s Technology-First Operating System Further Powers Syneos Health’s Decentralized SolutionsMORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos...
Fifteen Medical Societies Now Recommend Icosapent Ethyl to Reduce Cardiovascular Risk, Further Supporting that VASCEPA® is Rapidly Becoming a New Standard of Care
Recent recommendations or guidances, from Canada and Egypt, expand the global recognition of this important therapy and its demonstrated favorable...
Progressive Care Announces Annual Audited 2020 Report Earnings Call and Business Update on April 1st, 2021
MIAMI, FL, March 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,”...
I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates
18 significant clinical milestones achieved since the Company’s IPO in January 2020, with multiple important data readouts for lemzoparlimab (TJC4),...
Akouos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
- In 2020, continued to advance genetic medicine pipeline with execution of IND-enabling studies for AK-OTOF and general alignment with...
Myovant Sciences Announces European Medicines Agency Validation of Marketing Authorization Application for Relugolix for the Treatment of Advanced Prostate Cancer
If approved, relugolix would be the first and only oral androgen deprivation therapy for advanced prostate cancer in EuropeRelugolix is...
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
First and only tongue-delivered neuromodulation therapy provides new treatment option for U.S. patients living with gait deficit due to symptoms...
Erasca Appoints Bihua Chen and Julie Hambleton, M.D., to its Board of Directors
Ms. Chen, portfolio manager at Cormorant Asset Management, and Dr. Hambleton, a physician-turned-biotech executive, bring decades of experience to their...
PaceMate™ Closes Series A Financing to Accelerate Growth
BRADENTON, Fla.--(BUSINESS WIRE)--#EPeeps--PaceMate™, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a recent $8...
Acquisition of Immune Pharmaceuticals
Unconditional offer in relation to acquire the public entity FORT LEE, VA / ACCESSWIRE / March 29, 2021 / Immune...
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
VANCOUVER, BC / ACCESSWIRE / March 28, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") is pleased to...
AgraFlora Announces AGM Voting Results
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31)...
Kraig Biocraft Laboratories Secures $4 Million Dollars of Expansion Capital
ANN ARBOR, Mich., March 26, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced...
DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting
Montrouge, France, March 26, 2021 DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual...
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., March 26, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing...
Tauriga Sciences Inc. Announces Upcoming Commercial Launch of its Enhanced, 25mg CBD & CBG Infused, Version of Tauri-Gum
NEW YORK, NY, March 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
EssilorLuxottica : Disclosure of Share Capital and Voting Rights Outstanding as of March 25, 2021
Disclosure of Share Capital and Voting Rights Outstanding as of March 25, 2021 (Pursuant to Article L.233-8 II of the...
EssilorLuxottica : 2020 Universal Registration Document filed
2020 Universal Registration Document filed Charenton-Le-Pont, France (March 26, 2021 – 6:00 pm) – EssilorLuxottica announces the availability of its...
OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer, OSE-127/S95011 in ulcerative colitis, FR104...